Logo of Elixinol Wellness (ASX:EXL)Latest Elixinol Wellness (ASX:EXL) News

Page 1
Page 1 of 3

Elixinol widens margins as Vitable deal tests its leaner Australian model

Elixinol Wellness lifted Q3 gross profit 27% and delivered a fourth consecutive quarter of positive underlying operating cash flow, despite statutory operating cash flow remaining negative and cash below A$1 million. The proposed all-scrip Vitable acquisition could add scale, but shareholder approval and a thin liquidity buffer remain important next tests.
Victor Sage
14 Oct 2026

Elixinol hemp sales reach $6.41 million as gross profit accelerates

Elixinol Wellness has lifted combined hemp sales 12% to $6.41 million in the first nine months of 2026, while unaudited gross profit rose 41%. Two major grocery programs are now fully supplied through 2027, with Hemp Gold Protein due back at Costco in Australia and New Zealand.
Victor Sage
13 Oct 2026

Market Wrap - Week 39 (21 Sept -> 25 Sept) 2026

Small-cap resources led the week’s biggest moves, but sharp falls in Bounty Oil and Nyrada showed how quickly investors can sell when funding and deal terms remain uncertain.
Gold, copper, rare earths and takeover activity supplied the strongest gains, while several companies still need more cash before they can deliver their plans.
Logan Eniac
26 Sept 2026

Elixinol Adds 7,850 Subscribers in A$2.5m Vitable Scrip Deal

Elixinol Wellness will acquire personalised supplement platform Vitable for headline consideration of A$2.5 million in shares, adding recurring revenue and more than 7,850 active subscribers. The deal could lift combined revenue to A$27 million by 2028, but remains subject to shareholder approval and carries meaningful dilution risk.
Victor Sage
24 Sept 2026

Elixinol Wellness Completes US Business Sale for A$465,000

Elixinol Wellness has finalized the divestment of its US operations to Ananda Health, securing upfront and deferred payments totaling approximately A$465,000. This move refocuses the company on its Australian health and wellness portfolio while reducing exposure to US regulatory risks.
Victor Sage
7 Sept 2026

Elixinol Wellness Reports Record Revenue and Margin Lift with Sustained Cash Flow

Elixinol Wellness (ASX: EXL) has posted a record quarterly revenue of A$4.3 million alongside a 45% gross margin, marking a clear shift from its US CBD origins to a diversified Australian wellness platform. Cost reductions and disciplined cash flow management underpin the company’s readiness to scale.
Victor Sage
7 Aug 2026

Elixinol Wellness Hits Record $4.3 Million Revenue with Rising Margins and Cash Flow Gains

Elixinol Wellness posted a record quarterly revenue of $4.3 million in Q2 FY26, driven by The Healthy Chef's expansion and a 45% gross margin. Cost cuts helped deliver positive underlying operating cash flow for the third straight quarter despite some one-off expenses.
Victor Sage
28 July 2026

Elixinol Sustains Margin Gains and Cash Flow Momentum in Q1 FY26

Elixinol Wellness maintained steady revenue at $3.5 million in Q1 FY26 while boosting gross margins to 45% and reporting a second consecutive quarter of positive underlying operating cash flow.
Victor Sage
21 Apr 2026

Elixinol Wellness Drives Growth with Cost Cuts and New Leadership in FY25

Elixinol Wellness reported a 9.5% revenue increase in Q4 FY25 alongside a 30% reduction in operating costs, setting a clear path to profitability under fresh executive leadership.
Victor Sage
12 Feb 2026

Elixinol’s Q4 Surge – Revenue Up, Costs Down, Cash Flow Turns Positive

Elixinol Wellness Ltd reported a 9.5% revenue increase in Q4 FY25 alongside a 30% cut in operating costs, achieving its first underlying operating cash flow positive quarter. The company’s strategic acquisitions and e-commerce growth underpin a clear path to profitability.
Victor Sage
29 Jan 2026

Elixinol Strengthens Balance Sheet with Revised Healthy Chef Deal

Elixinol Wellness has amended acquisition terms for The Healthy Chef after its US distributor exited, reducing earnout payments and refocusing growth efforts on Australia.
Victor Sage
18 Dec 2025

Elixinol Wellness Boosts Margins Amid Strategic Cost Cuts and Capital Raise

Elixinol Wellness reported steady Q3 revenue with a notable 300bps gross margin improvement, driven by e-commerce and core brands, while executing cost reduction initiatives supported by a $2.5 million capital raise.
Victor Sage
31 Oct 2025